James D Thompson

Title: Innovations of James D Thompson

Introduction

James D Thompson is an accomplished inventor based in Longmont, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for ocular diseases. With a total of three patents to his name, Thompson's work is recognized for its innovative approach to medical science.

Latest Patents

Thompson's latest patents include groundbreaking research on double-stranded RNA compounds targeting CASP2. These patents detail methods for treating patients suffering from or at risk of developing ocular diseases, disorders, or injuries. The treatment regimens involve the use of double-stranded RNA compounds that effectively down-regulate CASP2 expression, or pharmaceutically acceptable salts thereof. This innovative approach has the potential to transform treatment options for patients with ocular conditions.

Career Highlights

Thompson is currently associated with Quark Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Quark has positioned him as a key player in the pharmaceutical industry, particularly in the realm of ocular health.

Collaborations

Thompson collaborates with notable colleagues such as Shai Erlich and Rabia Ozden. These partnerships enhance the research environment and contribute to the innovative solutions being developed at Quark Pharmaceuticals.

Conclusion

James D Thompson's contributions to the field of pharmaceuticals, particularly through his patents on double-stranded RNA compounds, highlight his role as a leading inventor in ocular disease treatment. His ongoing work promises to bring new hope to patients facing these challenging conditions.